Suchergebnisse - "Yamamoto, Shohei"

PubPharm (12)

1

Immunogenicity and safety of single booster dose of KD-414 inactivated COVID-19 vaccine in adults : An open-label, single-center, non-randomized, controlled study in Japan

enthalten in: Human vaccines & immunotherapeutics | 2023

von Terada-Hirashima, J. | Takamatsu, Y. | Shimizu, Y. | +13

2

The association between antipyretic analgesics use and SARS-CoV-2 antibody titers following the second dose of the BNT162b2 mRNA vaccine : An observational study

enthalten in: Vaccine | 2023

von Inoue, Y. | Li, Y. | Yamamoto, S. | +8

3

Omicron BA.1 neutralizing antibody response following Delta breakthrough infection compared with booster vaccination of BNT162b2

enthalten in: BMC infectious diseases | 2023

von Yamamoto, S. | Matsuda, K. | Maeda, K. | +11

4

Antibody responses and correlates after two and three doses of BNT162b2 COVID-19 vaccine

enthalten in: Infection | 2023

von Yamamoto, S. | Tanaka, A. | Oshiro, Y. | +4

5

Dyslipidemia and SARS-CoV-2 spike antibody titres after the second and third doses of the BNT162b2 vaccine among healthcare workers in Japan

enthalten in: Diabetes/metabolism research and reviews | 2023

von Islam, Z. | Yamamoto, S. | Mizoue, T. | +6

6

Neutralizing antibodies after three doses of the BNT162b2 vaccine, breakthrough infection, and symptoms during the Omicron-predominant wave

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2023

von Yamamoto, S. | Matsuda, K. | Maeda, K. | +13

7

Underlying medical conditions and anti-SARS-CoV-2 spike IgG antibody titers after two doses of BNT162b2 vaccination : A cross-sectional study

enthalten in: PloS one | 2023

von Li, J. | Nakagawa, T. | Kojima, M. | +13

8

SARS-CoV-2 specific T cell and humoral immune responses upon vaccination with BNT162b2 : a 9 months longitudinal study

enthalten in: Scientific reports | 2022

von Takeuchi, J. | Fukunaga, A. | Yamamoto, S. | +12

9

Coronavirus Disease 2019 (COVID-19) Breakthrough Infection and Post-Vaccination Neutralizing Antibodies Among Healthcare Workers in a Referral Hospital in Tokyo : A Case-Control Matching Study

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2022

von Yamamoto, S. | Maeda, K. | Matsuda, K. | +12

CommentIn: Clin Infect Dis. 2022 Aug 24;75(1):e692-e694. - PMID 35134147

10

Use of heated tobacco products, moderate alcohol drinking, and anti-SARS-CoV-2 IgG antibody titers after BNT162b2 vaccination among Japanese healthcare workers

enthalten in: Preventive medicine | 2022

von Yamamoto, S. | Tanaka, A. | Ohmagari, N. | +14